The estimated Net Worth of Timothy G Healey is at least $6.76 Millón dollars as of 23 February 2018. Timothy Healey owns over 3,696 units of Lantheus Inc stock worth over $6,207,328 and over the last 18 years Timothy sold LNTH stock worth over $552,255.
Timothy has made over 6 trades of the Lantheus Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently Timothy sold 3,696 units of LNTH stock worth $72,368 on 23 February 2018.
The largest trade Timothy's ever made was selling 11,314 units of Lantheus Inc stock on 17 November 2017 worth over $243,364. On average, Timothy trades about 1,425 units every 187 days since 2006. As of 23 February 2018 Timothy still owns at least 60,886 units of Lantheus Inc stock.
You can see the complete history of Timothy Healey stock trades at the bottom of the page.
Timothy's mailing address filed with the SEC is C/O ADVANCED MAGNETICS INC, 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR, CAMBRIDGE, MA, 02140.
Over the last 9 years, insiders at Lantheus Inc have traded over $500,725,766 worth of Lantheus Inc stock and bought 8,000 units worth $141,200 . The most active insiders traders include David F Burgstahler, Capital Partners Gp, Llc Av... y Sriram Venkataraman. On average, Lantheus Inc executives and independent directors trade stock every 11 days with the average trade being worth of $15,777,680. The most recent stock trade was executed by James H Thrall on 21 August 2024, trading 1,000 units of LNTH stock currently worth $98,520.
lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.
Lantheus Inc executives and other stock owners filed with the SEC include: